CIK 0001817713
- Large accelerated filer
Janux Therapeutics, Inc.
Sign in to watch- Ticker
- JANX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 822289112
- Phone
- +1 858-751-4493
- Business address
- 10955 VISTA SORRENTO PARKWAY, SUITE 200, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 38 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-01 | Meyer Andrew Hollman Chief Business Officer | Sale 10b5-1 | −2,700 | $32.85 | $89K | 85,607 |
| 2025-12-01 | Meyer Andrew Hollman Chief Business Officer | Sale 10b5-1 | −633 | $33.52 | $21K | 84,974 |
| 2025-12-01 | Meyer Andrew Hollman Chief Business Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −3,333 | 114,768 | ||
| 2025-11-14 | Meyer Andrew Hollman Chief Business Officer | Option exercise 10b5-1 | +3,333 | $10.59 | $35K | 88,307 |
| 2025-11-14 | Meyer Andrew Hollman Chief Business Officer | Sale 10b5-1 | −3,333 | $30.00 | $100K | 84,974 |
| 2025-11-14 | Meyer Andrew Hollman Chief Business Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −3,333 | 118,101 | ||
| 2025-10-28 | Meyer Andrew Hollman Chief Business Officer | Option exercise 10b5-1 | +9,999 | $4.21 | $42K | 92,138 |
| 2025-10-28 | Meyer Andrew Hollman Chief Business Officer | Option exercise 10b5-1 | +6,666 | $10.59 | $71K | 98,804 |
| 2025-10-28 | Meyer Andrew Hollman Chief Business Officer | Sale 10b5-1 | −16,665 | $30.06 | $501K | 82,139 |
| 2025-10-28 | Meyer Andrew Hollman Chief Business Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −9,999 | 77,333 | ||
| 2025-10-28 | Meyer Andrew Hollman Chief Business Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −6,666 | 121,434 | ||
| 2025-06-11 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award | +3,750 | 6,250 | ||
| 2025-06-11 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | +11,667 | 11,667 | ||
| 2025-06-11 | Barrett Ronald W Director | Grant or award | +3,750 | 6,250 | ||
| 2025-06-11 | Barrett Ronald W Director | Grant or award · Stock Option (right to buy) | +11,667 | 11,667 | ||
| 2025-06-11 | CAPPS VICKIE L Director | Grant or award | +3,750 | 74,098 | ||
| 2025-06-11 | CAPPS VICKIE L Director | Grant or award · Stock Option (right to buy) | +11,667 | 11,667 | ||
| 2025-06-11 | DOBMEIER ERIC Director | Grant or award | +3,750 | 9,981 | ||
| 2025-06-11 | DOBMEIER ERIC Director | Grant or award · Stock Option (right to buy) | +11,667 | 11,667 | ||
| 2025-06-11 | Gujrathi Sheila Director | Grant or award | +3,750 | 118,889 |
Page 3 of 15 · 294 trades